SABCS 2022: The Uncharted Territory of HER2-low Breast Cancer
Imagine a series of switches on a wall. When a patient is diagnosed with cancer, physicians often decide which...
Imagine a series of switches on a wall. When a patient is diagnosed with cancer, physicians often decide which...
Guest post by the Biopharma Collaborative Core Team In 2019, AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) embarked...
recent data suggest that there is another potential contender for a biomarker-based FDA approval: a targeted therapeutic called larotrectinib...
Researchers, physicians, patients, and other stakeholders convened in San Antonio, Texas, December 6-10 for the annual San Antonio Breast...
Researchers are examining the gut microbiome to find better ways to diagnose and manage colorectal cancer.
By Trevan Locke, PhD Thanks to a wave of newly approved therapies in the past two decades, survival rates...
Event cochair Dr. Michael Caligiuri shares how attendees can form connections to take science from bench to market.
Expanding clinical trial eligibility requirements can help increase participation and more accurately show how treatments work in a real-world...
For June, the editors of the AACR’s 10 journals chose to spotlight a characterization of an investigational KRAS inhibitor,...
Guest Post by Matthew J. Sikora, PhD University of Pittsburgh Cancer Institute
NCI Director Kimryn Rathmell evoked Taylor Swift to present her vision of the 360 era for cancer research.
A plenary session at the AACR Annual Meeting 2024 explored how metastases adapt to—and help shape—their new environments.
At the AACR Annual Meeting 2024, researchers discussed innovative approaches to decipher the complexities of tumor ecosystems.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in...
Philadelphia Eagles player Rodney McLeod he has looked to honor his grandmother’s memory by supporting the American Association for...
Just days before the start of multiple myeloma awareness month, which began Sunday, March 1, the U.S. Food and...
This past week has included good news for some patients with lung cancer and bad news for those with...
Attendees gathered firsthand information on all things breast cancer during the five-day San Antonio Breast Cancer Symposium, which showcased...
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a revolutionary new type of immunotherapy...
Karriem Watson is a public health expert serving as chief engagement officer of the National Institutes of Health’s All...
Today is International Day of Women and Girls in Science, a United Nations initiative aimed at encouraging full and...
Every two minutes, a woman somewhere in the world dies of cervical cancer. That harrowing statistic, shared by Anna R....
Head and neck cancers encompass a large group of malignancies that originate in the nasal cavity, sinuses, lips, mouth,...
In recent decades, the cancer research community has made great strides by bringing new, targeted, safer, and longer-lasting treatments...
Today, the American Association for Cancer Research (AACR) released its sixth annual Cancer Progress Report. The report highlights how...
The U.S. Latino population surged 243 percent from 1980 to 2010. But in the same time span, the Latino...
A recent estimate suggests that more than 40 percent of cancers could be prevented. Modifiable factors linked to cancer...
Guest Post by T.J. Sharpe Originally appeared on Philly.com's Patient #1 blog
Virtual scientific meetings have become the “new normal” in the COVID-19 era, enabling researchers to present and discuss recent...